Drugs News and Research

RSS

Diabetes drug dulaglutide may reduce symptoms of depression

The current study highlighted the antidepressant effects of dulaglutide using the CMS depression model. Notably, the potential metabolisms that underlie the antidepressant effect of dulaglutide have been elucidated in this study.

8 Mar 2024

Advances in the treatment of disorders of consciousness through multidisciplinary approaches

Emerging trends and new developments in the care and management of patients with disorders of consciousness (DoC) are increasingly focused on a multidisciplinary approach that integrates evidence-based assessment, treatment, and ethical aspects.

7 Mar 2024

The state of the union is … busy

President Joe Biden is working to lay out his health agenda for a second term, even as Congress races to finish its overdue spending bills for the fiscal year that began last October.

7 Mar 2024

When it comes to ketamine, Meta’s posting policy is no party to decipher

People keep talking about ketamine. The drug has become a favorite of celebrities, billionaires, and ordinary patients, many of whom view it as a potential miracle drug for depression and other mental health conditions.

7 Mar 2024

Gut bacteria strains could be the key to predicting cancer treatment success

Researchers discovered that gut microbiota strains can predict the effectiveness and adverse effects of immune checkpoint blockade (ICB) therapy in rare cancer patients.

6 Mar 2024

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Cancer is one of the most common causes of death in children worldwide. A research team in which the University of Würzburg is involved wants to change this – and has now received substantial funding for its work.

6 Mar 2024

UAB study identifies new molecule for treating hypertension

Researchers at the UAB have carried out two revealing studies on TRPV2, a key ion channel in several cellular functions, which points to it as a possible new therapeutic target in the treatment of hypertension.

6 Mar 2024

Study provides insights into the action and specificity of splice-modifying drugs

Spinal muscular atrophy, or SMA, is the leading genetic cause of infant death. Less than a decade ago, Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer showed this brutal disease can be treated by tweaking a process called RNA splicing.

6 Mar 2024

Breakthrough nanopipette enables real-time observation of cancer cell reactions to treatment

The high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has - for the first time - enabled researchers to see how individual living cancer cells react to treatment and change over time – providing vital understanding that could help doctors develop more effective cancer medication.

6 Mar 2024

Noninvasive gamma therapy may hold promise for treating chemo brain

Patients undergoing chemotherapy often experience cognitive effects such as memory impairment and difficulty concentrating - a condition commonly known as "chemo brain."

6 Mar 2024

Study reveals link between blood amyloid levels and brain microstructure changes in Alzheimer's

New research published today suggests there is a link between abnormal blood levels of amyloid - a protein associated with Alzheimer's disease - and subtle changes in brain microstructures on a type of MRI, findings that could lead to a new way to detect Alzheimer's earlier in people with no clinical signs.

6 Mar 2024

Biden is right. The US generally pays double that of other countries for Rx drugs.

It's well documented that Americans pay high prices for health care. But do they pay double or more for prescriptions compared with the rest of the world? President Joe Biden said they did.

6 Mar 2024

Novel screening system reveals sperm cell development and health at the molecular level

A novel screening system developed at Kyoto University enables researchers to investigate sperm cell development and health at the molecular level.

5 Mar 2024

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

Drugs News and Research

Diabetes drug dulaglutide may reduce symptoms of depression

Advances in the treatment of disorders of consciousness through multidisciplinary approaches

The state of the union is … busy

When it comes to ketamine, Meta’s posting policy is no party to decipher

Gut bacteria strains could be the key to predicting cancer treatment success

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

UAB study identifies new molecule for treating hypertension

Study provides insights into the action and specificity of splice-modifying drugs

Breakthrough nanopipette enables real-time observation of cancer cell reactions to treatment

Noninvasive gamma therapy may hold promise for treating chemo brain

Study reveals link between blood amyloid levels and brain microstructure changes in Alzheimer's

Biden is right. The US generally pays double that of other countries for Rx drugs.

Novel screening system reveals sperm cell development and health at the molecular level

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

Scientists design breakthrough drug to combat deadly pancreatic cancer mutation

New catheter-based device images heart disease plaques with unprecedented detail

Researchers examine the immune response of a hypervaccinated individual

Nomogram could be a game-changer for predicting alcohol-related liver cancer risk

DNA aptamer-based sensors can accurately detect trace amounts of fentanyl, heroin, and cocaine

Study finds lower cardiovascular risks in hyperthyroid patients treated with surgery or radioactive iodine

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News